News

May 4, 2026

Dexoligo Therapeutics is pleased to announce that we will be presenting at the 2026 Israel Nucleic Acid Therapeutics Meeting

April 16, 2026

Dexoligo Therapeutics will be attending the 5th Israeli Translational & Clinical Conference - Myeloproliferative Neoplasms & Myeloid Disease

December 1, 2025

Dexoligo Therapeutics presented a poster at the American Society of Hematology conference (ASH 2025), Orlando